RC
ZBH icon

Rovin Capital’s Zimmer Biomet ZBH Stock Holding History

Rovin Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$518K Buy
5,762
+296
+5% +$28.1K 0.14% 118
2025
Q3 		$538K Buy
5,466
+61
+1% +$6.04K 0.15% 111
2025
Q2 		$493K Buy
5,405
+579
+12% +$56K 0.15% 111
2025
Q1 		$546K Sell
4,826
-143
-3% -$15.3K 0.18% 93
2024
Q4 		$525K Sell
4,969
-1,457
-23% -$156K 0.19% 94
2024
Q3 		$694K Buy
6,426
+1,029
+19% +$112K 0.26% 87
2024
Q2 		$586K Buy
5,397
+645
+14% +$76K 0.24% 83
2024
Q1 		$627K Buy
4,752
+737
+18% +$92.1K 0.26% 79
2023
Q4 		$489K Buy
4,015
+779
+24% +$86.9K 0.22% 87
2023
Q3 		$363K Sell
3,236
-286
-8% -$36.3K 0.17% 90
2023
Q2 		$513K Sell
3,522
-126
-3% -$17.1K 0.23% 69
2023
Q1 		$471K Sell
3,648
-535
-13% -$67.2K 0.22% 75
2022
Q4 		$533K Sell
4,183
-194
-4% -$22.5K 0.27% 62
2022
Q3 		$458K Sell
4,377
-152
-3% -$16.7K 0.26% 65
2022
Q2 		$476K Buy
4,529
+67
+2% +$7.95K 0.32% 62
2022
Q1 		$571K Buy
4,462
+673
+18% +$81.1K 0.3% 55
2021
Q4 		$467K Buy
+3,789
New +$496K 0.22% 72

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Rovin Capital's ZBH Position: Q4 2025 in Review

Rovin Capital increased its Zimmer Biomet (ZBH) stake by 5.4% in Q4 2025, buying an estimated $28.1K and bringing the position to 5,762 shares worth $518K. The position accounts for 0.14% of the portfolio, ranked #118.

Rovin Capital first reported a position in ZBH in Q4 2021 and has held it in 17 quarters since. The position peaked at $694K in Q3 2024. 945 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Rovin Capital held 5,762 shares of Zimmer Biomet worth $518K as of Q4 2025.
  • Rovin Capital bought 296 Zimmer Biomet shares in Q4 2025, an estimated $28.1K.
  • Zimmer Biomet made up 0.14% of Rovin Capital's portfolio in Q4 2025, its #118 holding.
  • Rovin Capital first reported a position in Zimmer Biomet in Q4 2021 and has held it in 17 quarters since.
  • Rovin Capital's Zimmer Biomet position peaked at $694K in Q3 2024.
  • 945 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.